Patent details

EP2187901 Title: Neuropeptide El optionally combined with ACTH (7-38) for use in anti-angiogenic therapy

Basic Information

Publication number:
EP2187901
PCT Application Number:
PCT/EP/2008/007522
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP088020821
PCT Publication Number:
WO/2009/039978
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Neuropeptide El optionally combined with ACTH (7-38) for use in anti-angiogenic therapy
French Title of Invention:
Neuropeptide El éventuellement combiné à l'ACTH (7-38) à utiliser dans la thérapie anti-angiogénique
German Title of Invention:
Neuropeptid El und optional ACTH (7-38) zur Verwendung in der antiangiogenen Therapie
SPC Number:

Dates

Filing date:
09/09/2008
Grant date:
08/08/2012
EP Publication Date:
08/08/2012
PCT Publication Date:
02/04/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/05/2010
EP B1 Publication Date:
08/08/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/09/2012
Expiration date:
09/09/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/09/2008
 
 

Name:
Mondobiotech Laboratories AG
Address:
Herrengasse 21, 9490 Vaduz, Liechtenstein (LI)

Inventor

1

Name:
CAVALLI Vera
Address:
Switzerland (CH)

2

Name:
BACHER Gerald
Address:
Germany (DE)

3

Name:
BEVEC Dorian
Address:
Germany (DE)

4

Name:
CAVALLI Fabio
Address:
Switzerland (CH)

Priority

Priority Number:
07017750
Priority Date:
11/09/2007
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 38/10;
Filing date Document type Number of pages